Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.

Bjånes TK, Jordheim LP, Schjøtt J, Kamceva T, Cros-Perrial E, Langer A, Ruiz de Garibay G, Kotopoulis S, McCormack E, Riedel B.

Drug Metab Dispos. 2020 Mar;48(3):153-158. doi: 10.1124/dmd.119.089334. Epub 2019 Dec 23.

PMID:
31871136
2.

Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.

Ghoteimi R, Nguyen VT, Rahimova R, Grosjean F, Cros-Perrial E, Uttaro JP, Mathé C, Chaloin L, Jordheim LP, Peyrottes S.

ChemMedChem. 2019 Aug 6;14(15):1431-1443. doi: 10.1002/cmdc.201900348. Epub 2019 Jul 25.

PMID:
31264794
3.

CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.

Dumontet C, Peyrottes S, Rabeson C, Cros-Perrial E, Géant PY, Chaloin L, Jordheim LP.

Eur J Med Chem. 2018 Sep 5;157:1051-1055. doi: 10.1016/j.ejmech.2018.08.035. Epub 2018 Aug 17.

PMID:
30176535
4.

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.

Jordheim LP, Chettab K, Cros-Perrial E, Matera EL, Dumontet C.

Pharmacology. 2018;102(3-4):161-168. doi: 10.1159/000491587. Epub 2018 Jul 26.

PMID:
30048976
5.

The cytosolic 5'-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells.

Bricard G, Cadassou O, Cassagnes LE, Cros-Perrial E, Payen-Gay L, Puy JY, Lefebvre-Tournier I, Tozzi MG, Dumontet C, Jordheim LP.

Oncotarget. 2017 Jun 27;8(40):67380-67393. doi: 10.18632/oncotarget.18653. eCollection 2017 Sep 15.

6.

Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.

Puy JY, Jordheim LP, Cros-Perrial E, Dumontet C, Peyrottes S, Lefebvre-Tournier I.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 May 15;1053:101-110. doi: 10.1016/j.jchromb.2017.03.024. Epub 2017 Mar 24.

PMID:
28415014
7.

Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II.

Bricard G, Cros-Perrial E, Machon C, Dumontet C, Jordheim LP.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):604-612.

PMID:
27906612
8.

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents.

Chettab K, Roux S, Mathé D, Cros-Perrial E, Lafond M, Lafon C, Dumontet C, Mestas JL.

PLoS One. 2015 Aug 14;10(8):e0134247. doi: 10.1371/journal.pone.0134247. eCollection 2015.

9.

Use of designed experiments for the improvement of pre-analytical workflow for the quantification of intracellular nucleotides in cultured cell lines.

Machon C, Bordes C, Cros-Perrial E, Clement Y, Jordheim LP, Lanteri P, Guitton J.

J Chromatogr A. 2015 Jul 31;1405:116-25. doi: 10.1016/j.chroma.2015.05.069. Epub 2015 Jun 6.

PMID:
26094139
10.

Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

Cividini F, Cros-Perrial E, Pesi R, Machon C, Allegrini S, Camici M, Dumontet C, Jordheim LP, Tozzi MG.

Int J Biochem Cell Biol. 2015 Aug;65:222-9. doi: 10.1016/j.biocel.2015.06.011. Epub 2015 Jun 14.

PMID:
26079827
11.

Determination of the enzymatic activity of cytosolic 5'-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models.

Jordheim LP, Puy JY, Cros-Perrial E, Peyrottes S, Lefebvre I, Périgaud C, Dumontet C.

Anal Bioanal Chem. 2015 Jul;407(19):5747-58. doi: 10.1007/s00216-015-8757-4. Epub 2015 May 22.

PMID:
25998135
12.

The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

Cividini F, Pesi R, Chaloin L, Allegrini S, Camici M, Cros-Perrial E, Dumontet C, Jordheim LP, Tozzi MG.

Biochem Pharmacol. 2015 Mar 15;94(2):63-8. doi: 10.1016/j.bcp.2015.01.010. Epub 2015 Feb 2.

PMID:
25656700
13.

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.

Jordheim LP, Cros-Perrial E, Matera EL, Bouledrak K, Dumontet C.

Clin Exp Pharmacol Physiol. 2014 Oct;41(10):817-24. doi: 10.1111/1440-1681.12282.

PMID:
25115435
14.

Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells.

Jordheim LP, Barakat KH, Heinrich-Balard L, Matera EL, Cros-Perrial E, Bouledrak K, El Sabeh R, Perez-Pineiro R, Wishart DS, Cohen R, Tuszynski J, Dumontet C.

Mol Pharmacol. 2013 Jul;84(1):12-24. doi: 10.1124/mol.112.082347. Epub 2013 Apr 11.

PMID:
23580445
15.

Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.

Jordheim LP, Marton Z, Rhimi M, Cros-Perrial E, Lionne C, Peyrottes S, Dumontet C, Aghajari N, Chaloin L.

Biochem Pharmacol. 2013 Feb 15;85(4):497-506. doi: 10.1016/j.bcp.2012.11.024. Epub 2012 Dec 7.

PMID:
23220537
16.

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.

Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel D, Vendrell JA, Dumontet C.

Cancer Chemother Pharmacol. 2011 Jul;68(1):97-105. doi: 10.1007/s00280-010-1458-y. Epub 2010 Sep 16.

PMID:
20844879
17.

Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells.

Hébrard C, Cros-Perrial E, Clausen AR, Dumontet C, Piskur J, Jordheim LP.

Nucleosides Nucleotides Nucleic Acids. 2009 Nov;28(11):1068-75. doi: 10.1080/15257770903368393.

PMID:
20183574

Supplemental Content

Loading ...
Support Center